Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:2916-2923

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vassalli, G.
Right arrow Articles by Hess, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vassalli, G.
Right arrow Articles by Hess, O. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITROGLYCERIN

(Circulation. 1995;91:2916-2923.)
© 1995 American Heart Association, Inc.


Articles

Reduced Epicardial Coronary Vasodilator Capacity in Patients With Left Ventricular Hypertrophy

Giuseppe Vassalli, MD; Philipp Kaufmann, MD; Bruno Villari, MD; Markus Jakob, MD; Hildegard Boj, RN; Wolfgang Kiowski, MD; Otto M. Hess, MD

From the Department of Internal Medicine, Cardiology, University Hospital, Zurich, Switzerland.

Correspondence to Otto M. Hess, MD, Cardiology, University Hospital, Raemistrasse 100, 8091 Zurich, Switzerland.

Background Enlargement of the epicardial coronary arteries occurs in left ventricular (LV) hypertrophy as an adaptation to the increased coronary blood flow.

Methods and Results Vasodilator capacity of the epicardial coronary arteries was determined in 44 patients. The dose-response relation of intracoronary nitroglycerin was assessed in 14 patients (7 control subjects and 7 patients with aortic stenosis [study A]) using quantitative coronary angiography. In a second study (B), vasodilator capacity of the epicardial coronary arteries was determined in 15 control subjects and 15 patients with valvular heart disease. In study A, a curvilinear dose-response relation with maximal vasodilation after 90 µg intracoronary nitroglycerin was found in both control subjects and patients with aortic stenosis. Vasodilator capacity was reduced in those with aortic stenosis, although sensitivity to nitroglycerin was similar in both groups. In study B, coronary circumferential length at baseline was larger in those with LV hypertrophy (12.2±2.2 mm) than in control subjects (8.6±1.5 mm; P<.001); after 100 µg intracoronary nitroglycerin, it increased to 12.9±2.2 mm (6±5%) in those with LV hypertrophy and to 10.3±1.5 mm (21±8%; P<.001) in control subjects. An inverse relation between baseline circumferential length and its percent increase after nitroglycerin was found (r=-.71, P<.001).

Conclusions Vasodilator capacity of the epicardial coronary arteries is reduced in patients with LV hypertrophy, although sensitivity to nitroglycerin is normal. This may be due to a flow-mediated decrease in coronary vasomotor tone and/or the occurrence of vascular remodeling with an enlargement of the coronary arteries.


Key Words: vasodilation • hypertrophy • nitroglycerin • stenosis • ventricles




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. Sicari, A. Palinkas, E. G. Pasanisi, L. Venneri, and E. Picano
Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET)
Eur. Heart J., October 2, 2005; 26(20): 2136 - 2141.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Saotome, H. Satoh, A. Uehara, H. Katoh, H. Terada, and H. Hayashi
Coronary Ectasia with Slow Flow Related to Apical Hypertrophic Cardiomyopathy: A Case report
Angiology, January 1, 2005; 56(1): 103 - 106.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Jorg-Ciopor, M. Namdar, J. Turina, R. Jenni, J. Schwitter, M. Turina, O. M. Hess, and P. A. Kaufmann
Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D J R Hildick-Smith and L M Shapiro
Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy
Heart, June 1, 2001; 85(6): 615 - 619.
[Full Text]


Home page
J Am Coll CardiolHome page
D. J. R. Hildick-Smith and L. M. Shapiro
Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1889 - 1896.
[Abstract] [Full Text] [PDF]